2016 Life Sciences Symposium (academic sessions)

Location and program details 

Bates White
1300 Eye Street NW, Suite 600 
Washington, DC 20005

Monday, May 23

8:40–9:10 a.m.

• Chirantan Chatterjee, Indian Institute of Management
  The consumer welfare implications of governmental policies and firm strategy in markets for medicines

9:20–9:50 a.m.

• Ben Roin, Massachusetts Institute of Technology
  Missing markets for innovation: Evidence from new uses of old drugs

10:10–10:40 a.m.

• Tomas Philipson, University of Chicago
  Financial health economics: Hedging government risk

10:50–11:20 a.m.

• Ernst Berndt, Massachusetts Institute of Technology
  Prescription drug spending in the US: Is the era of slow growth over?

2:30–3:00 p.m.

• Pierre Dubois, University of Toulouse
  Estimating the benefits of cancer treatments

3:10–3:40 p.m.

• Mark Pauly, University of Pennsylvania
  A demand-side explanation for changing R&D productivity

4:00–4:30 p.m.

• Fred Selck, Bates White
  Case study: Irreparable harm and public interest

Tuesday,  May 24

8:30–9:00 a.m.

• David McAdams, Duke University
  Spoilable IP

9:10–9:40 a.m.

• Ariel Stern, Harvard University
  Market entry of biosimilars: Evidence from Europe

9:50–10:20 a.m.

• Matthew Grennan, University of Pennsylvania
  Can big data lower health care costs?

10:40–11:10 a.m.

• Neeraj Sood, University of Southern California
  Abby Alpert, University of California, Irvine 
  Effects of DTCA on drug utilization and adherence

11:20–11:50 a.m.

• Frank Lichtenberg, Columbia University
  Listen to your doctor, or else!: Medication under-use and overuse and long-term health outcomes of Danish diabetes patients

1:00–1:30 p.m.

• David Grabowski, Harvard Medical School
  The value of new anticancer drugs

1:40–2:10 p.m.

• Ashley Swanson, University of Pennsylvania
  Pass-through in a highly regulated supply chain: The who, what, and when of the US drug market

2:30–3:00 p.m.

• Aaron Yelowitz, University of Kentucky
  Evaluating the effects of the False Claims Act on Medicaid expenditure growth, using state-level data

3:10–3:40 p.m.

• Bill Comanor, University of California, Los Angeles
  Ted Frech, University of California, Santa Barbara 
  Are generic pharmacutical prices increasing at a staggering rate?

Registration
If you are interested in attending, please email Ngar Eldredge.